Read more about Nureca IPO subscribed 14.77 times on Business Standard. The issue received bids for 2.07 crore shares as against 14.01 lakh shares on offer.
Dr Reddys Laboratories Ltd has lost 15.47% over last one month compared to 6.47% fall in S&P BSE Healthcare index and 2.8% drop in the SENSEX
Dr Reddys Laboratories Ltd fell 3.67% today to trade at Rs 4430. The S&P BSE Healthcare index is down 0.91% to quote at 20440.81. The index is down 6.47 % over last one month. Among the other constituents of the index, Thyrocare Technologies Ltd decreased 3.01% and RPG Life Sciences Ltd lost 2.97% on the day. The S&P BSE Healthcare index went up 48.83 % over last one year compared to the 17.09% surge in benchmark SENSEX.
Dr Reddys Laboratories Ltd has lost 15.47% over last one month compared to 6.47% fall in S&P BSE Healthcare index and 2.8% drop in the SENSEX. On the BSE, 12647 shares were traded in the counter so far compared with average daily volumes of 42068 shares in the past one month. The stock hit a record high of Rs 5514.65 on 21 Sep 2020. The stock hit a 52-week low of Rs 2497.6 on 19 Mar 2020.
Medall Healthcare recovers from the pandemic. But profits, innovation hold key to an IPO in 2024.
Image credit: Medall via Facebook
Synopsis
Medall was facing challenges much before Covid-19. The constant chatter and murmurs of a major investor’s exit had started to visibly affect the day-to-day operations at the company and that is when Raju Venkatraman, the then CEO, retired. Investor Peepul Capital’s Arjun Ananth stepped in to reorient the business.
Back in November 2019, as the winter was about to set in across India, Medall Healthcare had to swallow a bitter pill. The company’s founder and chief executive officer, Raju Venkatraman, had decided to hang his boots. Venkatraman, a serial entrepreneur, had started the company in 2009 after buying Precision Diagnostics and he led the company to become one of the top five diagnostics service providers in the country at present.So, what
The issue received bids for 1.62 crore shares as against 2.23 crore shares on offer.
The initial public offer (IPO) of Home First Finance Company India received bids for 1.62 crore shares as against 2.23 crore shares on offer on Thursday (21 January 2021), according to the stock exchange data at 17:30 IST. The issue was subscribed 0.73 times.
The issue opened for subscription on Thursday (21 January 2021) and it will close on Monday (25 January 2021). The price band for the IPO is set at Rs 517-518 per share. An investor can bid for minimum of 28 equity shares and in multiples thereof.
The IPO consists of fresh issue of equity shares aggregating to Rs 265 crore and an offer of sale of equity shares aggregating up to Rs 888.71 crore (including anchor portion of 66.81 lakh equity shares).
The issue received bids for 3.84 crore shares as against 55.18 lakh shares on offer.
The initial public offer (IPO) of Indigo Paints received bids for 3.84 crore shares as against 55.18 lakh shares on offer on Thursday (21 January 2021), according to the stock exchange data at 17:30 IST. The issue was subscribed 6.97 times.
The issue opened for subscription on Wednesday (20 January 2021) and it will close on Friday (22 January 2021). The price band for the IPO is set at Rs 1488-1490 per share. An investor can bid for minimum of 10 equity shares and in multiples thereof.
The IPO consists of fresh issue of equity shares aggregating to Rs 300 crore and an offer of sale of up to 58.40 lakh equity shares by the selling shareholders.